To further clarify the implication of TGF-β in malaria morbidity, we took advantage of novel anti-TGF-β antibody pairs to selectively measure TGF-β1 [13] and TGF-β3 [14] plasma concentrations in a panel of control and infected patients in Rwanda. The gene discussed is TGFB3; the disease is malaria.